ERCP Malpractice Note
Side effects after an ERCP can range from mild to life-threatening. Severe ERCP side effects include pancreatitis, organ perforation, infection, hemorrhage, and death. If you have questions about problems after an ERCP, call 888.726.6735
ERCP Side Effects
Endoscopic retrograde cholangiopancreatography (ERCP) can be helpful in treating specific medical conditions involving the bile and pancreatic ducts. However, ERCP side effects pose a risk to the patient. ERCP side effects can be life-threatening, such as organ perforation or infection. Doctors should carefully evaluate whether or not an ERCP procedure is the right choice for diagnosing and treating a patient’s condition.
ERCP Recovery
Due to the anesthetics and sedation required, the patient should be monitored after an ERCP procedure. Monitoring can help medical professionals determine if the patient is experiencing any immediate ERCP side effects. Additionally, the patient often requires time to allow the sedatives and anesthetics to wear off.
Common ERCP side effects occur immediately after the procedure, including:
- Mild, temporary sore throat
- Temporary tiredness of difficulty concentrating
- Bloating, due to air introduced during the procedure
Severe ERCP Side Effects
While severe ERCP side effects are rare, they can be life-threatening. The risk of death significantly increases if the conditions are not immediately diagnosed. Beginning immediately after the procedure, patients should report all unusual sensations and ailments to their doctor.
Pancreatitis
Pancreatitis, or inflammation of the pancreas, is one of the most common ERCP side effects. Pancreatitis after ERCP is estimated to occur in roughly three to 10 percent of ERCP patients. In many cases, pancreatitis after ERCP occurs in mild cases. However, severe pancreatitis may be life threatening. Patients with severe pancreatitis after ERCP require hospitalization and professional treatment.
Organ Perforation
Dangerous ERCP side effects include organ perforation, or a tear or hole in an organ’s wall. Organ perforation is rare. When this occurs, surgical intervention is often necessary to fix the perforation and prevent further damage from occurring.
Infection
Infection is one of the most common causes of death after an ERCP procedure. Cholangitis, or infection of the common bile duct, may occur. Cholangitis is treated as a medical emergency and should be treated immediately. Cholecystitis is another type of dangerous infection affecting the gallbladder. Cholecystitis also requires immediate medical attention.
Over Sedation
Since an ERCP procedure involves sedation and anesthesia, the patient is at risk for being over-sedated. This is considered a form of ERCP malpractice, as over-sedation is typically a result of neglect or lack of experience from the medical professional who administered the sedatives. Patients who are over-sedated may experience respiratory depression, dangerously low blood pressure, nausea, and vomiting.
ERCP Side Effects
Patients should seek a doctor immediately if they experience the following ERCP side effects:
- Severe, worsening abdominal pain
- A distended, firm abdomen
- Fever or chills
- Vomiting, especially vomiting blood
- Difficulty swallowing or breathing
- Severe sore throat
Sources:
Cotton, Peter B, et al. “Analysis of 59 ERCP lawsuits; mainly about indications.” Gastrointestinal Endoscopy. 63.3 (2006): 378-382. Web. 21 Jun. 2013. <http://www.ncbi.nlm.nih.gov/pubmed/16500382>.
“Endoscopic retrograde cholangiopancreatography (ERCP).” The Sol Goldman Pancreatic Cancer Research Center. Johns Hopkins University, 12 Nov 2012. Web. 21 Jun 2013. <http://pathology.jhu.edu/pc/ercp.php>.
“ERCP Benefits, Risks, Side Effects.” Indiana University Department of Medicine. Indiana University, 10 Jun 2011. Web. 21 Jun 2013. <http://medicine.iupui.edu/ERCP/about/risks.asp&xgt>.
Lehman, Glen A., et al. “Risk Factors For Post-ERCP Pancreatitis: A Prospective Multicenter Study.” The American Journal of Gastroenterology 101.1 (2006): 139-147. MEDLINE with Full Text. Web. 21 June 2013.